Cart
sales@molnova.com
DL-Buthionine-(SR)-sulfoximine
CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine( Butionine sulfoximine | NSC 381100 )
Catalog No. M20963 CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 39 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDL-Buthionine-(SR)-sulfoximine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
-
DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
-
In Vitro——
-
In Vivo——
-
SynonymsButionine sulfoximine | NSC 381100
-
PathwayOthers
-
TargetOther Targets
-
Recptorγ-glutamylcysteine synthetase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5072-26-4
-
Formula Weight222.31
-
Molecular FormulaC8H18N2O3S
-
Purity>98% (HPLC)
-
SolubilityH2O:41.67 mg/mL (187.44 mM; Need ultrasonic)
-
SMILESCCCCS(=N)(=O)CCC(N)C(=O)O
-
Chemical Name2-amino-4-(butylsulfonimidoyl)butanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arrick B. A . Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis[J]. Journal of Experimental Medicine 1981 153(3):720-725.
molnova catalog
related products
-
2'-Deoxy-2'-fluorour...
2'-Deoxy-2'-fluorouridine is an antiinfluenza virus agents synthesis intermediate.
-
Orientalide
Orientalide is a natural product for research related to life sciences.
-
Necroptosis-IN-3
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.
